Researchers have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine. The research was conducted in mouse models. The network is working toward the development of a new smallpox vaccine that could be administered to eczema sufferers.